Clinical Trial Update: Efficacy and Tolerability of Combination Antihypertensive Drug in Non-Responders to ARB monoTHerapy Using 24h ABPM [Phase 4]

View source ↗

Summary

Phase 4 study assessing the efficacy and tolerability of a combination antihypertensive therapy in patients not responding to ARB monotherapy, evaluated using 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Combination antihypertensive drug (ARB non-responder regimen)

Snippet

Sponsor: Sang Hyun Ihm, MD PhD | Conditions: Hypertension | Phase 4 | Status: COMPLETED